The Pharmaceutical Out-licensing Course

THE CONTENT

Out-licensing an R&D compound is a critical and highly challenging process in the biopharma industry, with significant strategic and financial implications. Success depends on thorough preparation and strategic planning well before engaging with potential partners. Early missteps can jeopardise your chances of securing the right deal.

This course equips you with a clear framework and proven best practices to effectively prepare for and manage the out-licensing process from opportunity assessment and partner identification to negotiations and contract finalisation.

If you want to position your assets for success and avoid costly missteps in the out-licensing process, this course is an essential investment!

THE EXPERT

David Scott is a recognised authority in pharmaceutical business development and licensing.